Clinical Trials
26 trialsStudy of Factors Regulating Mast Cell Proliferation
National Institutes of Health Clinical Center (CC)
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Blueprint Medicines Corporation
DATAMAST
Imagine Institute
An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
Blueprint Medicines Corporation
A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany
Blueprint Medicines Corporation
EGR2
Assistance Publique - Hôpitaux de Paris
Institutional Registry of Rare Diseases
Hospital Italiano de Buenos Aires
IgE-PhD
KU Leuven
KID-Tryp
Assistance Publique - Hôpitaux de Paris
Myeloproliferative Neoplasms (MPNs) Patient Registry
University Health Network, Toronto
MastoR
University of Zurich
Relationship Between Circulating Sclerostin and Bone Lesions in Patients With Mastocytosis
Medical University of Lublin
Angioedema Biomarker Research Study
Foundation For Rare Disease Research
DALY-MAST
University Hospital, Toulouse
Study of Mast Cell Precursors
National Institutes of Health Clinical Center (CC)
Mast Cell Connect: A Registry for Patients With Mastocytosis
Blueprint Medicines Corporation
MCD&BuDi
University Hospital, Toulouse
Mast Cell Activation Test in Allergic Disease
Hong Kong Sanatorium & Hospital
Cause and Natural Course of Pediatric-Onset Mastocytosis
National Institutes of Health Clinical Center (CC)
Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders
National Institutes of Health Clinical Center (CC)
The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy
Meir Medical Center
Molecular Mechanisms and Diagnosis of Mastocytosis
University of Michigan
UP
Medical College of Wisconsin
Characteristics of Mast Cells in Mastocytosis
National Institutes of Health Clinical Center (CC)
Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing
National Institutes of Health Clinical Center (CC)
Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals
National Institutes of Health Clinical Center (CC)